- Home
- DSGN vs HMST Comparison
DSGN vs HMST Comparison
Compare DSGN & HMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- HMST
- Stock Information
- Founded
- DSGN 2017
- HMST 1921
- Country
- DSGN United States
- HMST United States
- Employees
- DSGN N/A
- HMST N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- HMST Major Banks
- Sector
- DSGN Health Care
- HMST Finance
- Exchange
- DSGN Nasdaq
- HMST Nasdaq
- Market Cap
- DSGN 264.4M
- HMST 287.6M
- IPO Year
- DSGN 2021
- HMST 2012
- Fundamental
- Price
- DSGN $5.57
- HMST $11.29
- Analyst Decision
- DSGN Hold
- HMST Buy
- Analyst Count
- DSGN 3
- HMST 2
- Target Price
- DSGN $7.00
- HMST $13.25
- AVG Volume (30 Days)
- DSGN 142.1K
- HMST 245.4K
- Earning Date
- DSGN 11-07-2024
- HMST 10-29-2024
- Dividend Yield
- DSGN N/A
- HMST 3.46%
- EPS Growth
- DSGN N/A
- HMST N/A
- EPS
- DSGN N/A
- HMST N/A
- Revenue
- DSGN N/A
- HMST $169,710,000.00
- Revenue This Year
- DSGN N/A
- HMST N/A
- Revenue Next Year
- DSGN N/A
- HMST $10.09
- P/E Ratio
- DSGN N/A
- HMST N/A
- Revenue Growth
- DSGN N/A
- HMST N/A
- 52 Week Low
- DSGN $2.13
- HMST $5.98
- 52 Week High
- DSGN $7.77
- HMST $16.10
- Technical
- Relative Strength Index (RSI)
- DSGN 47.80
- HMST 42.00
- Support Level
- DSGN $5.32
- HMST $10.52
- Resistance Level
- DSGN $7.77
- HMST $11.80
- Average True Range (ATR)
- DSGN 0.58
- HMST 0.60
- MACD
- DSGN -0.09
- HMST 0.18
- Stochastic Oscillator
- DSGN 19.12
- HMST 80.59
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.